• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS, INC OPS FIBER 55CM SPOTLIGHT; VENACURE ENDOVENOUS LASER TREATMENT FIBER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS, INC OPS FIBER 55CM SPOTLIGHT; VENACURE ENDOVENOUS LASER TREATMENT FIBER Back to Search Results
Catalog Number H787EVLT55OPS5
Medical Device Problem Codes Thermal Decomposition of Device (1071); Fracture (1260)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/05/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The reported defective device has yet to be returned to the manufacturer for a device evaluation.The firm is attempting to obtain the device.An investigation into the root cause for product problem is currently in progress.The results of the device evaluation will be sent via a follow up medwatch.Reference complaint # (b)(4).
 
Event or Problem Description
Post procedure, end of evlt ops fiber appeared to be burnt.When viewed under microscope that the surface of the ops has totally been burned, indicating the fiber had fractured.There was no reported patient harm or injury due to the event.It was reported the disposable device is available for return to the manufacturer for a device evaluation.
 
Additional Manufacturer Narrative
Returned for evaluation was an 55-ops evlt fiber.A visual evaluation of the disposable device noted the fiber tip end exhibited discoloration and appeared to be burnt.During functional testing, it was noted the fiber had been previously fired.The power output was considered to be low, which could have been potentially caused by the burnt cladding.This complaint event was incorrectly identified as a fiber fracture.The tip of the fiber was burnt/discolored.Upon sample evaluation, it was determined this complaint does not meet the criteria of a reportable event.This supplemental med watch is being submitted in order to close the complaint file.A review of the angiodynamics' device history records was performed for the reported packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly, and performance specifications.The directions for use, which is supplied to the end user with this catalog number, contains the following statement "the end user is to align the compression clamp with the proximal site mark on the fiber and then tighten the compression clamp.The sheath is then to be withdrawn (with optical fiber) at a rate consistent with the venous anatomy".A review of the angiodynamics complaint system noted no trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPS FIBER 55CM SPOTLIGHT
Common Device Name
VENACURE ENDOVENOUS LASER TREATMENT FIBER
Manufacturer (Section D)
ANGIODYNAMICS, INC
603 queensbury avenue
queensbury NY 12804
MDR Report Key8134935
Report Number1319211-2018-00122
Device Sequence Number1693061
Product Code GEX
UDI-Device IdentifierH787EVLT55OPS5
UDI-PublicH787EVLT55OPS5
Combination Product (Y/N)N
Initial Reporter CountryNL
PMA/510(K) Number
K041957
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,user facility
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date (Section B) 03/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/30/2021
Device Catalogue NumberH787EVLT55OPS5
Device Lot Number5316927
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/07/2019
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/07/2018
Supplement Date Received by Manufacturer11/07/2018
Initial Report FDA Received Date12/05/2018
Supplement Report FDA Received Date03/28/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age63 YR
-
-